Wells Fargo & Company Exact Sciences Corp Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Exact Sciences Corp stock. As of the latest transaction made, Wells Fargo & Company holds 137,330 shares of EXAS stock, worth $6.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,330

Previous 127,027 8.11%

Holding current value

$6.53 Million

Previous $7.14 Million 16.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$43.04 - $58.51 $443,441 - $602,828	10,303 Added 8.11%	137,330 $5.95 Million
Q4 2024 Feb 12, 2025	SELL	$49.33 - $71.97 $945,508 - $1.38 Million	-19,167 Reduced 13.11%	127,027 $7.14 Million
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $110,827 - $185,007	2,612 Added 1.82%	146,194 $9.95 Million
Q2 2024 Aug 13, 2024	SELL	$41.33 - $74.26 $6.25 Million - $11.2 Million	-151,281 Reduced 51.31%	143,582 $6.07 Million
Q1 2024 May 10, 2024	SELL	$56.27 - $73.77 $2.6 Million - $3.4 Million	-46,119 Reduced 13.53%	294,863 $20.4 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $5.4 Million - $6.92 Million	-91,353 Reduced 21.13%	340,982 $25.2 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $3.36 Million - $5.05 Million	51,030 Added 13.38%	432,335 $29.5 Million
Q2 2023 Aug 15, 2023	BUY	$62.68 - $95.05 $641,843 - $973,312	10,240 Added 2.76%	381,305 $35.8 Million
Q1 2023 May 12, 2023	BUY	$47.19 - $70.77 $4.7 Million - $7.05 Million	99,554 Added 36.67%	371,065 $25.2 Million
Q4 2022 Feb 13, 2023	SELL	$30.35 - $53.15 $151,021 - $264,474	-4,976 Reduced 1.8%	271,511 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $636,330 - $982,660	19,904 Added 7.76%	276,487 $8.98 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $616,409 - $1.32 Million	17,310 Added 7.23%	256,583 $10.1 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $4.05 Million - $5.81 Million	70,402 Added 41.69%	239,273 $16.7 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $4.08 Million - $5.67 Million	-56,313 Reduced 25.01%	168,871 $13.1 Million
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $2.41 Million - $3.31 Million	-26,719 Reduced 10.61%	225,184 $21.5 Million
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $6.14 Million - $9.13 Million	-65,532 Reduced 20.64%	251,903 $31.3 Million
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $194 Million - $258 Million	-1,667,154 Reduced 84.01%	317,435 $41.8 Million
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $28.4 Million - $40.5 Million	-284,843 Reduced 12.55%	1,984,589 $263 Million
Q3 2020 Nov 05, 2020	SELL	$72.92 - $102.01 $71.4 Million - $99.9 Million	-979,061 Reduced 30.14%	2,269,432 $231 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $12.7 Million - $21.1 Million	227,010 Added 7.51%	3,248,493 $282 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $115 Million - $316 Million	3,021,483 New	3,021,483 $175 Million

Others Institutions Holding EXAS

# of Institutions

638

Shares Held

156M

Call Options Held

1.64M

Put Options Held

1.5M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.41B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Exact Sciences Corp Transaction History